We expect continued additional medication switching in the coming months
Similarly, SGLT2 inhibitors may be continued, although clinicians should monitor for dehydration or electrolyte imbalance
However, Hims still does not include a PHQ-2 depression screener, and the lifestyle history remains fairly light, with only a single 5-point activity scale rather than deeper diet-history questions
The table lists provider credentials, medication sourcing, whether the platform offers peptide pathway or biomarker evaluation, cost transparency, and clinical follow-up
(2023) reported higher Tyr levels compared with healthy individuals (Moritz et al., 2023)